← FDA Drug Approvals (Drugs@FDA)

BANZEL

NDA · New Drug Application · Sponsor: EISAI INC · Approved 2008-11-14

Drug application

FDA Application #
NDA021911
Application type
New Drug Application
Brand name
BANZEL
Generic name
RUFINAMIDE
Active ingredients
RUFINAMIDE
Dosage form
TABLET
Route
ORAL
Marketing status
Discontinued
Sponsor
EISAI INC
Manufacturer
Eisai Inc.
First approval
2008-11-14

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown